Speech-Language Pathologists in Savage, MD Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Laura Ann Baur Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8200 Savage Guilford Rd, Savage, MD 20763 Phone: 410-880-5920 |
Ilana Pearl Roth, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8200 Savage Guilford Rd, Savage, MD 20763 Phone: 410-880-5920 |
News Archive
Combining machine learning with brain imaging tools can redefine the standard for diagnosing mental illnesses
Most of modern medicine has physical tests or objective techniques to define much of what ails us. Yet, there is currently no blood or genetic test, or impartial procedure that can definitively diagnose a mental illness, and certainly none to distinguish between different psychiatric disorders with similar symptoms.
Study says public health strategies can be applied to prevent bullying and suicide
Recent studies linking bullying and depression, coupled with extensive media coverage of bullying-related suicide among young people, led the Centers for Disease Control and Prevention (CDC) to assemble an expert panel to focus on these issues. This panel synthesized the latest research about the complex relationship between youth involvement in bullying and suicide-related behaviors.
Investigational device to treat brain cancer shows promise in early studies
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
The Wistar Institute and partners receive HIV cure research grant to test novel immunotherapies
The Wistar Institute is pleased to announce that the National Institutes of Health has awarded a nearly $23 million Martin Delaney Collaboratories for HIV Cure Research grant to the BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, a consortium of top HIV researchers led by co-principal investigators Luis J. Montaner, D.V.M., D.Phil., director of the HIV-1 Immunopathogenesis Laboratory at The Wistar Institute Vaccine Center, and James L. Riley, Ph.D., research associate professor at the Perelman School of Medicine at the University of Pennsylvania.
Cognition Therapeutics closes $2.5 million Series A1 financing
Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.
› Verified 2 days ago